Thomas M. Patton
President and Chief Executive Officer
Thomas M. Patton joined CASMED in August 2010 as President and CEO. Previously, Mr. Patton acted as an advisor to the healthcare-focused private equity group of Ferrer Freeman & Company, LLC and as CEO of QDx, Inc., a successful start-up that developed a revolutionary platform for hematology diagnostics. Mr. Patton has previously served as the CEO of Wright Medical Group, an orthopedic device company in Memphis, Tennessee, and as President of Novametrix Medical Systems, a patient monitoring company in Wallingford, Connecticut. He graduated from The College of the Holy Cross and magna cum laude from Georgetown University Law Center.
Jeffery A. Baird
Chief Financial Officer
Jeffery A. Baird joined CASMED in January 2004 as Chief Financial Officer. He has over 25 years of extensive financial management experience in the medical products industry. Before joining CASMED, Mr. Baird was CFO of QDx, Inc., a start-up venture engaged in the development of a revolutionary platform for hematology diagnostics. Prior to his tenure at QDx, Mr. Baird held various financial positions at Novametrix Medical Systems including Controller, Treasurer, and CFO. Before joining Novametrix, Mr. Baird was employed by Philips Medical Systems.
Brian J. Wagner
Chief Commercial Officer
Mr. Wagner joined CASMED in October 2013 as Chief Commercial Officer. Prior to his joining the company, he served as Senior Vice President and Chief Marketing Officer for Philips Imaging Systems, a $7 billion revenue business, where he led worldwide marketing across eight operating devisions. Mr. Wagner held a series of executive management positions at Kimberly-Clark Health Care, including General Manager of the Global Pain and Temperature Management Division and Vice President of Global Strategic Marketing and Business Development. His experience also includes serving as Vice President and General Manager of Rubbermaid Healthcare, a medical division which he developed and launched, focusing on electronic medical administrative records. Additionally, he held various sales and marketing management positions of increasing responsibility with Guidant Corporation and Boston Scientific during years of unprecendeted growth. Mr. Wagner earned his Master's from Harvard University and a Backelor of Science from Miami University of Ohio.
Dr. John K. Gamelin
Vice President - Research and Development
John Gamelin joined CASMED in 2009, became the Director of Research and Development in 2010, and was appointed to Vice President of Research and Development in 2012. He has more than 20 years of experience inventing and developing optical, acoustic, and electronic instrumentation, from research concept to commercial production. Previously, as a co-founder and Vice President of Engineering for Tellium, an optical switching company, he was instrumental in driving that company from start-up to over $100 million in revenues in just four years. He began his career as a Senior Scientist at Bellcore, the research and engineering organization for the Regional Bell Operating Companies. Dr. Gamelin holds four U.S. patents in optical cross-connects and switching technology and several patent applications in biomedical imaging and medical instrumentation. He is the author or co-author of more than 50 publications on topics that include biomedical imaging and laser transmitters. He received his Ph.D. in electrical engineering from the University of California and was Valedictorian for his graduating undergraduate class at the University of Florida.
Dr. Paul B. Benni
Chief Scientific Officer
Dr. Benni joined CASMED in 1998, and in 2006 became Chief Scientific Officer. Dr. Benni is the primary inventor of the company’s FORE-SIGHT® Tissue Oximeter, a near-infrared spectroscopy (NIRS) -based device to monitor the oxygen saturation of the brain and other tissues of the human body non-invasively by using various wavelengths of light. With the support of several grants from the National Institutes for Health for his unique approach, Dr. Benni made possible the development and first commercialization of FORE-SIGHT for CASMED in 2007. Guided by Dr. Benni’s continued refinement of the technology and algorithms, the performance of the FORE-SIGHT monitor continues to define the category. Dr. Benni graduated from Rutgers, The State University of New Jersey, in 1990 with a B.S. in Electrical Engineering and in 1999 with a Ph.D. in Biomedical Engineering focused on NIRS research. Prior to attending graduate school, Dr. Benni worked as an engineer with GE Astrospace on satellites and the Mars Observer spacecraft. Dr. Benni holds several patents on NIRS technology and authored several peer-reviewed journal articles on the topic.